🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to investigate whether a 3-week treatment with an ...
Status
Completed
Location
UZLeuven
Start Date
2018-12-20
Trial ID
NCT03883074
Treatments Being Tested
The optimal EAA-containing protein format necessary to maximally stimulate ...
Status
Completed
Location
US Army Research Institute of Environmental Medicine
Start Date
2019-04-25
Trial ID
NCT04004715
Treatments Being Tested
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-31
Trial ID
NCT01678677
Treatments Being Tested
In this study two different tablets for oral use of a known investigational...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-09-30
Trial ID
NCT04097600
Treatments Being Tested
To compare plasma GSK706769 PK following repeat administration of GSK706769...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07-24
Trial ID
NCT00723775
Treatments Being Tested
GSK1349572 is an integrase inhibitor being developed for the treatment of h...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01209065
Treatments Being Tested
The purpose of the study is to compare tacrolimus dosing of the new Envarsu...
Status
Completed
Location
Chiesi farmaceutici Spa
Start Date
2015-05
Trial ID
NCT02432833
The purpose of this study is to investigate the safety and pharmacokinetics...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT02042729
Incompatibility between evidence-based treatments (EBTs) and the cultural v...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01
Trial ID
NCT07425366
The primary purpose of this study is to measure and compare the amount of s...
Status
Completed
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2024-11-05
Trial ID
NCT06670170
Treatments Being Tested